In the US, Palifermin (palifermin systemic) is a member of the drug class miscellaneous uncategorized agents and is used to treat Mucositis.
US matches:
- Palifermin
- Palifermin Intravenous
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
V03AF08
CAS registry number (Chemical Abstracts Service)
0162394-19-6
Chemical Formula
C724-H1147-N203-O206-S9
Molecular Weight
16279
Therapeutic Categories
Growth factor
Fibrinoblast Growth Factor, human
Chemical Names
24-163 fibroblast growht factor 7 (human) (USAN)
human fibroblast growth factor-(24-163)-peptide (WHO)
Peptide-(24-163)-facteur de croissance du fibroblaste humain
Peptido-(24-163)-factor de crecimiento del fibroblasto humano
Foreign Names
- Paliferminum (Latin)
- Palifermin (German)
- Palifermine (French)
- Palifermina (Spanish)
Generic Names
- Palifermin (OS: USAN)
- Keratinocyte Growth Factor (IS: Amgen)
- KGF (IS)
- rh KGF (IS)
- rHu-KGf (IS)
Brand Names
- Kepivance
Amgen, United Arab Emirates; Amgen, Austria; Amgen, Belgium; Amgen, Bahrain; Amgen, Czech Republic; Amgen, Germany; Amgen, Egypt; Amgen, Spain; Amgen, Finland; Amgen, Hungary; Amgen, Ireland; Amgen, Iraq; Amgen, Iran; Amgen, Italy; Amgen, Jordan; Amgen, Kuwait; Amgen, Lebanon; Amgen, Luxembourg; Amgen, Norway; Amgen, Oman; Amgen, Poland; Amgen, Qatar; Amgen, Saudi Arabia; Amgen, Syria; Amgen, United States; Amgen, Yemen; Amgen Switzerland, Switzerland; Biovintrum, Greece; Biovitrum, France; Biovitrum, United Kingdom; Biovitrum, Sweden; Biovitrum AB, Netherlands; PharmaLink, Australia; Amgen Europe B.VNL, Denmark
International Drug Name Search
Glossary
IS | Inofficial Synonym |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
WHO | World Health Organization |
Click for further information on drug naming conventions and
International Nonproprietary Names.